← Back to patent-cliff list
CAS 195197-94-5
tert-butyl (3-((tert-butyldimethylsilyl)oxy)-2-hydroxypropyl)carbamate
Codes: PXS-4728-002
Application context (from source-drug indications)
REM睡眠行为障碍PXS-4728Diabetic retinopathyPXS-4728Non-alcoholic steatohepatitisPXS-4728Renal impairmentPXS-4728
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| PXS-4728 | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
PXS-4728→3-aminopropane-1,2-diol→tert-butyl (3-((tert-butyldimethylsilyl)oxy)-2-hydroxypropyl)carbamate→tert-butyl (3-((tert-butyldimethylsilyl)oxy)-2-oxopropyl)carbamate→tert-butyl (2-(((tert-butyldimethylsilyl)oxy)methyl)-3-fluoroallyl)carbamate→(E)-tert-butyl (3-fluoro-2-(hydroxymethyl)allyl)carbamate→(E)-tert-butyl (2-(bromomethyl)-3-fluoroallyl)carbamate→N-(tert-butyl)-4-hydroxybenzamide→(E)-tert-butyl (2-((4-(tert-butylcarbamoyl)phenoxy)methyl)-3-fluoroallyl)carbamate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.